Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
XORTX Therapeutics Inc. (XRTX) had Free Cash Flow per Share of $-0.38 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.72M |
|
-- |
|
-- |
|
$0.89M |
|
$-0.89M |
|
$0.17M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.72M |
|
$-0.89M |
|
$-0.86M |
|
3.79M |
|
3.79M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$1.26M |
|
$0.08M |
|
$1.48M |
|
$2.74M |
|
$0.71M |
|
-- |
|
-- |
|
$0.71M |
|
$2.03M |
|
$1.84M |
|
$2.03M |
|
3.79M |
|
| Cash Flow Statement Financials | |
$-1.44M |
|
$-0.03M |
|
$0.02M |
|
$2.47M |
|
$1.06M |
|
$-1.41M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.78 |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.34% |
|
-39.10% |
|
-26.17% |
|
-35.34% |
|
$0.54 |
|
|
Free Cash Flow per Share |
$-0.38 |
$-0.38 |
|